In the rapidly advancing realm of synthetic biology, a remarkable innovation is capturing the attention of scientists and industry leaders alike: the potential to produce proteins outside the confines of living cells using synthetic transfer RNA (tRNA) arrays. This cutting-edge development,
In the rapidly evolving field of synthetic biology, a groundbreaking study from the University of Warwick has unveiled a transformative approach to enhance the productivity of engineered microbial cell factories, as detailed in a recent publication in Nature Communications . These microscopic
In a groundbreaking move that has captured the attention of both the pharmaceutical industry and economic analysts, Eli Lilly and Co. has unveiled plans for a staggering $5 billion biomanufacturing facility in Goochland County, Virginia. Nestled in the West Creek Business Park, just a short
The pharmaceutical industry stands at a critical juncture, where the urgent need for faster, more sustainable, and patient-focused solutions is driving unprecedented change, as vividly demonstrated at the DCAT Summit held on June 4–5 in Lugano, Switzerland. Under the compelling theme "Expedition
In a striking move that underscores the growing emphasis on domestic manufacturing in the biopharmaceutical sector, Amgen, a titan in the American biotech landscape, has committed a substantial $650 million to expand its biologics facility in Juncos, Puerto Rico. This investment is not merely a
Lipid reprogramming has emerged as a critical frontier in understanding and treating clear cell renal cell carcinoma (ccRCC), the predominant subtype of kidney cancer that accounts for a significant portion of cases worldwide. This metabolic transformation, where tumor cells drastically alter how
